IN2012MU01383A - - Google Patents

Download PDF

Info

Publication number
IN2012MU01383A
IN2012MU01383A IN1383MU2012A IN2012MU01383A IN 2012MU01383 A IN2012MU01383 A IN 2012MU01383A IN 1383MU2012 A IN1383MU2012 A IN 1383MU2012A IN 2012MU01383 A IN2012MU01383 A IN 2012MU01383A
Authority
IN
India
Application number
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to PCT/IN2013/000296 priority Critical patent/WO2013179300A2/en
Priority to IN1383MU2012 priority patent/IN2012MU01383A/en
Publication of IN2012MU01383A publication Critical patent/IN2012MU01383A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
IN1383MU2012 2012-05-04 2013-05-03 IN2012MU01383A (ar)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IN2013/000296 WO2013179300A2 (en) 2012-05-04 2013-05-03 A process for the preparation of vildagliptin and its intermediate thereof
IN1383MU2012 IN2012MU01383A (ar) 2012-05-04 2013-05-03

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1383MU2012 IN2012MU01383A (ar) 2012-05-04 2013-05-03

Publications (1)

Publication Number Publication Date
IN2012MU01383A true IN2012MU01383A (ar) 2014-02-28

Family

ID=49213010

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1383MU2012 IN2012MU01383A (ar) 2012-05-04 2013-05-03

Country Status (2)

Country Link
IN (1) IN2012MU01383A (ar)
WO (1) WO2013179300A2 (ar)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021116897A1 (en) * 2019-12-10 2021-06-17 Optimus Drugs (P) Ltd Process for the preparation of vildagliptin

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015092806A1 (en) * 2013-12-18 2015-06-25 Harman Finochem Limited An advanced and cost-effective process for preparing highly pure vildagliptin
CN103724248B (zh) * 2014-01-16 2018-07-27 万全万特制药江苏有限公司 维格列汀工艺杂质的制备方法
CN103804267B (zh) * 2014-02-21 2016-06-08 张家港威胜生物医药有限公司 一种维达列汀的合成工艺
CN103896819B (zh) * 2014-03-25 2016-02-24 宁波美诺华药业股份有限公司 一种(s)-1-氯乙酰基吡咯烷-2-甲酰胺的制备方法
WO2015145467A1 (en) * 2014-03-28 2015-10-01 Laurus Labs Private Limited An improved process for preparing vildagliptin
CN103992257B (zh) * 2014-05-16 2016-03-30 苏州天马精细化学品股份有限公司 一种维格列汀粗品的纯化方法
CN104016895A (zh) * 2014-06-24 2014-09-03 万特制药(海南)有限公司 一种维达列汀氧化杂质的制备方法
CN105439873A (zh) * 2014-08-20 2016-03-30 天津药物研究院 3-羟基-1-金刚烷胺的制备方法
CN104311467B (zh) * 2014-09-11 2017-07-21 上海医药集团青岛国风药业股份有限公司 管式反应连续制备维格列汀的方法及装置
CN104262227B (zh) * 2014-09-16 2018-09-18 东北制药集团股份有限公司 一种制备(s)-1-(2-氯乙酰基)吡咯烷-2-甲腈的方法
CN104945299B (zh) * 2015-05-28 2017-03-15 烟台万润药业有限公司 一种维格列汀的高效合成方法
CN105037234B (zh) * 2015-07-30 2017-10-24 上海医药集团青岛国风药业股份有限公司 一种维格列汀降解杂质的制备方法
CN105085360A (zh) * 2015-09-10 2015-11-25 南京理工大学 一种高纯度维格列汀的制备方法
CN105193752B (zh) * 2015-10-27 2018-03-30 石家庄康贺威药业有限公司 一种维格列汀片剂及其制备方法
CN106117104B (zh) * 2016-06-17 2018-11-20 东北制药集团股份有限公司 一种维格列汀的制备方法
CN106699627A (zh) * 2016-12-29 2017-05-24 青岛黄海制药有限责任公司 一种多相复式非连续生产法制备1‑(2‑氯乙酰基)‑2‑(s)‑氰基吡咯烷的方法
CN107325010A (zh) * 2017-08-14 2017-11-07 四川众邦制药有限公司 一种金刚烷醇的安全制备方法及装置
CN110117122B (zh) * 2019-06-17 2022-03-01 卢玉献 一种羟丙甲生产废水处理方法
WO2022003405A1 (en) 2020-07-03 2022-01-06 Savoi Guilherme One-pot process to obtain a pyrrolidine-2-carbonitrile intermediate compound and industrial scale telescopic process to prepare (2s)-1-[n-(3-hydroxyadamantan-1-yl)glycyl]-2-pyrrolidinecarbonitrile (vildagliptin) using same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5150173A1 (es) 1998-12-10 2002-04-29 Novartis Ag Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv
AR044019A1 (es) * 2003-04-16 2005-08-24 Novartis Ag Proceso para la preparacion de 2-cianopirrolidinas n-sustituidas
GT200600008A (es) 2005-01-18 2006-08-09 Formulacion de compresion directa y proceso
WO2008084383A2 (en) * 2007-01-10 2008-07-17 Medichem, S.A. Process for preparing vildagliptin
CA2704493A1 (en) * 2007-11-30 2009-06-04 Novartis Ag Organic compounds
CZ2008512A3 (cs) * 2008-08-26 2010-03-10 Zentiva, A. S Zpusob prípravy vysoce cistého vildagliptinu
WO2011101861A1 (en) * 2010-01-29 2011-08-25 Msn Laboratories Limited Process for preparation of dpp-iv inhibitors

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021116897A1 (en) * 2019-12-10 2021-06-17 Optimus Drugs (P) Ltd Process for the preparation of vildagliptin

Also Published As

Publication number Publication date
WO2013179300A2 (en) 2013-12-05
WO2013179300A3 (en) 2014-08-28

Similar Documents

Publication Publication Date Title
BR112014017635A2 (ar)
BR112014019131A2 (ar)
BR112014017614A2 (ar)
BR112014017625A2 (ar)
BR112014017659A2 (ar)
BR112014017646A2 (ar)
BR112014017638A2 (ar)
IN2012MU01383A (ar)
BR112013027865A2 (ar)
BR112014017634A2 (ar)
BR112014017609A2 (ar)
BR112014017644A2 (ar)
BR112014020104A2 (ar)
BR112014017647A2 (ar)
BR112014017618A2 (ar)
BR112014019895A2 (ar)
BR112014013184A8 (ar)
BR112014017630A2 (ar)
BR112014017652A2 (ar)
BR112014017621A2 (ar)
BR112014017622A2 (ar)
BR112014017627A2 (ar)
BR112014017623A2 (ar)
BR112014018119A2 (ar)
BR112014017631A2 (ar)